NS
Nanalysis Scientific Corp.
NSCIF · OTC
$0.08 -16.07% (-$0.02)
1M +17.88%
Market Cap $19.5M
P/E Ratio -
Div. Yield -
ROE 33.44%
Bulios Fair Price
$0.04
52.4% downside
Current Price
$0.084
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NSCIF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
64 /100
Fair P/FCF 11.00x
P/B 1.58x
EV/EBITDA 63.84x
Growth
75 /100
Growing Book val. growth 27.44%
Rev. growth 17.37%
FCF growth N/A
Profitability
16 /100
Weak FCF margin 4.38%
Op. margin 5.03%
Gross margin 20.27%
Quality
15 /100
Poor Asset turnover 1.20x
ROA 12.43%
ROIC 7.57%
Debt
20 /100
High Net debt/EBITDA 26.05x
Int. coverage -1.88x
Debt/Equity 1.13x
Stability
28 /100
Unstable Profitable years 0
EPS volatility 52.99%
Beta -0.12x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NSCIF
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Sean Krakiwsky
Employees
15,299
Headquarters
Calgary
Upcoming events
23 NOV
Earnings
Upcoming earnings report